Literature DB >> 20451039

Accumulation of intraepithelial mast cells with a unique protease phenotype in T(H)2-high asthma.

Ryan H Dougherty1, Sukhvinder S Sidhu, Kavita Raman, Margaret Solon, Owen D Solberg, George H Caughey, Prescott G Woodruff, John V Fahy.   

Abstract

BACKGROUND: Previously, we found that mast cell tryptases and carboxypeptidase A3 (CPA3) are differentially expressed in the airway epithelium in asthmatic subjects. We also found that asthmatic subjects can be divided into 2 subgroups ("T(H)2 high" and "T(H)2 low" asthma) based on epithelial cell gene signatures for the activity of T(H)2 cytokines.
OBJECTIVES: We sought to characterize intraepithelial mast cells (IEMCs) in asthma.
METHODS: We performed gene expression profiling in epithelial brushings and stereology-based quantification of mast cell numbers in endobronchial biopsy specimens from healthy control and asthmatic subjects before and after treatment with inhaled corticosteroids (ICSs). We also performed gene expression and protein quantification studies in cultured airway epithelial cells and mast cells.
RESULTS: By means of unsupervised clustering, mast cell gene expression in the airway epithelium related closely to the expression of IL-13 signature genes. The levels of expression of mast cell genes correlate positively with lung function improvements with ICSs. IEMC density was 2-fold higher than normal in subjects with T(H)2-high asthma compared with that seen in subjects with T(H)2-low asthma or healthy control subjects (P = .015 for both comparisons), and these cells were characterized by expression of tryptases and CPA3 but not chymase. IL-13 induced expression of stem cell factor in cultured airway epithelial cells, and mast cells exposed to conditioned media from IL-13-activated epithelial cells showed downregulation of chymase but no change in tryptase or CPA3 expression.
CONCLUSION: IEMC numbers are increased in subjects with T(H)2-high asthma, have an unusual protease phenotype (tryptase and CPA3 high and chymase low), and predict responsiveness to ICSs. IL-13-stimulated production of stem cell factor by epithelial cells potentially explains mast cell accumulation in T(H)2-high asthmatic epithelium. Copyright 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20451039      PMCID: PMC2918406          DOI: 10.1016/j.jaci.2010.03.003

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  43 in total

1.  Increased numbers of both airway basophils and mast cells in sputum after allergen inhalation challenge of atopic asthmatics.

Authors:  G M Gauvreau; J M Lee; R M Watson; A M Irani; L B Schwartz; P M O'Byrne
Journal:  Am J Respir Crit Care Med       Date:  2000-05       Impact factor: 21.405

2.  A novel method of gene transcript profiling in airway biopsy homogenates reveals increased expression of a Na+-K+-Cl- cotransporter (NKCC1) in asthmatic subjects.

Authors:  G M Dolganov; P G Woodruff; A A Novikov; Y Zhang; R E Ferrando; R Szubin; J V Fahy
Journal:  Genome Res       Date:  2001-09       Impact factor: 9.043

3.  Relationship of small airway chymase-positive mast cells and lung function in severe asthma.

Authors:  Silvana Balzar; Hong Wei Chu; Matthew Strand; Sally Wenzel
Journal:  Am J Respir Crit Care Med       Date:  2004-11-24       Impact factor: 21.405

4.  Analysis of MC(T) and MC(TC) mast cells in tissue.

Authors:  Lawrence B Schwartz
Journal:  Methods Mol Biol       Date:  2006

5.  Phenotyping and cytokine regulation of the BEAS-2B human bronchial epithelial cell: demonstration of inducible expression of the adhesion molecules VCAM-1 and ICAM-1.

Authors:  J Atsuta; S A Sterbinsky; J Plitt; L M Schwiebert; B S Bochner; R P Schleimer
Journal:  Am J Respir Cell Mol Biol       Date:  1997-11       Impact factor: 6.914

6.  Human leukaemic (HMC-1) and normal skin mast cells express beta 2-integrins: characterization of beta 2-integrins and ICAM-1 on HMC-1 cells.

Authors:  S Weber; M Babina; G Feller; B M Henz
Journal:  Scand J Immunol       Date:  1997-05       Impact factor: 3.487

7.  Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production.

Authors:  Z Zhu; R J Homer; Z Wang; Q Chen; G P Geba; J Wang; Y Zhang; J A Elias
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

8.  Interleukin-4 and -13 expression is co-localized to mast cells within the airway smooth muscle in asthma.

Authors:  C E Brightling; F A Symon; S T Holgate; A J Wardlaw; I D Pavord; P Bradding
Journal:  Clin Exp Allergy       Date:  2003-12       Impact factor: 5.018

9.  Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma.

Authors:  Douglas A Kuperman; Xiaozhu Huang; Laura L Koth; Grace H Chang; Gregory M Dolganov; Zhou Zhu; Jack A Elias; Dean Sheppard; David J Erle
Journal:  Nat Med       Date:  2002-07-01       Impact factor: 53.440

10.  Development and characterization of a monoclonal antibody specific for human basophils and the identification of a unique secretory product of basophil activation.

Authors:  A R McEuen; M G Buckley; S J Compton; A F Walls
Journal:  Lab Invest       Date:  1999-01       Impact factor: 5.662

View more
  99 in total

1.  Alternative splicing of interleukin-33 and type 2 inflammation in asthma.

Authors:  Erin D Gordon; Laura J Simpson; Cydney L Rios; Lando Ringel; Marrah E Lachowicz-Scroggins; Michael C Peters; Agata Wesolowska-Andersen; Jeanmarie R Gonzalez; Hannah J MacLeod; Laura S Christian; Shaopeng Yuan; Liam Barry; Prescott G Woodruff; K Mark Ansel; Karl Nocka; Max A Seibold; John V Fahy
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-18       Impact factor: 11.205

Review 2.  Immunopathology of chronic rhinosinusitis.

Authors:  Atsushi Kato
Journal:  Allergol Int       Date:  2015-02-09       Impact factor: 5.836

3.  Characterization of a novel human mast cell line that responds to stem cell factor and expresses functional FcεRI.

Authors:  Tanya M Laidlaw; John W Steinke; Adrienne M Tiñana; Chunli Feng; Wei Xing; Bing K Lam; Sailaja Paruchuri; Joshua A Boyce; Larry Borish
Journal:  J Allergy Clin Immunol       Date:  2011-02-01       Impact factor: 10.793

4.  Glandular mast cells with distinct phenotype are highly elevated in chronic rhinosinusitis with nasal polyps.

Authors:  Tetsuji Takabayashi; Atsushi Kato; Anju T Peters; Lydia A Suh; Roderick Carter; James Norton; Leslie C Grammer; Bruce K Tan; Rakesh K Chandra; David B Conley; Robert C Kern; Shigeharu Fujieda; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2012-04-24       Impact factor: 10.793

Review 5.  Asthma phenotypes: the evolution from clinical to molecular approaches.

Authors:  Sally E Wenzel
Journal:  Nat Med       Date:  2012-05-04       Impact factor: 53.440

Review 6.  Pediatric exercise-induced bronchoconstriction: contemporary developments in epidemiology, pathogenesis, presentation, diagnosis, and therapy.

Authors:  Christopher Randolph
Journal:  Curr Allergy Asthma Rep       Date:  2013-12       Impact factor: 4.806

7.  Increased density of intraepithelial mast cells in patients with exercise-induced bronchoconstriction regulated through epithelially derived thymic stromal lymphopoietin and IL-33.

Authors:  Ying Lai; William A Altemeier; John Vandree; Adrian M Piliponsky; Brian Johnson; Cara L Appel; Charles W Frevert; Dallas M Hyde; Steven F Ziegler; Dirk E Smith; William R Henderson; Michael H Gelb; Teal S Hallstrand
Journal:  J Allergy Clin Immunol       Date:  2013-11-09       Impact factor: 10.793

Review 8.  Epithelial regulation of eicosanoid production in asthma.

Authors:  Teal S Hallstrand; Ying Lai; William R Henderson; William A Altemeier; Michael H Gelb
Journal:  Pulm Pharmacol Ther       Date:  2012-12       Impact factor: 3.410

9.  IL1RL1 asthma risk variants regulate airway type 2 inflammation.

Authors:  Erin D Gordon; Joe Palandra; Agata Wesolowska-Andersen; Lando Ringel; Cydney L Rios; Marrah E Lachowicz-Scroggins; Louis Z Sharp; Jamie L Everman; Hannah J MacLeod; Jae W Lee; Robert J Mason; Michael A Matthay; Richard T Sheldon; Michael C Peters; Karl H Nocka; John V Fahy; Max A Seibold
Journal:  JCI Insight       Date:  2016-09-08

10.  Regulation and function of epithelial secreted phospholipase A2 group X in asthma.

Authors:  Teal S Hallstrand; Ying Lai; William A Altemeier; Cara L Appel; Brian Johnson; Charles W Frevert; Kelly L Hudkins; James G Bollinger; Prescott G Woodruff; Dallas M Hyde; William R Henderson; Michael H Gelb
Journal:  Am J Respir Crit Care Med       Date:  2013-07-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.